# Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA

> **NCT01681823** · PHASE2 · COMPLETED · sponsor: **EcoNugenics** · enrollment: 60 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DIETARY_SUPPLEMENT:** PectaSol-C Modified Citrus Pectin (MCP)

## Key facts

- **NCT ID:** NCT01681823
- **Lead sponsor:** EcoNugenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01681823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01681823, "Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01681823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*